Opgen Inc

Ownership Transactions Reported by 22 Insiders

Symbol
OPGN on OTC
Industry
Services-Medical Laboratories
Location
9717 Key West Avenue, Suite 100, Rockville, MD

Insiders trading volume in the past year

Opgen Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Avraham Ben-Tzvi Director $85K Apr 11, 2024
David Natan Director $85K Apr 11, 2024
Matthew C. McMurdo Director $85K Apr 11, 2024
David E. Lazar Chief Executive Officer, Director, 10%+ Owner $85K +$350K Jul 30, 2024
Evan/ Fa Jones Director $19.2K May 17, 2021
Oliver Schacht Chief Executive Officer, Director $17.2K Mar 31, 2023
Johannes Bacher Chief Operating Officer $10.8K Mar 31, 2023
R. Don Elsey Director $2.61K Jun 7, 2023
Prabhavathi Fernandes Director $2.55K Jun 7, 2023
William E. Rhodes Director $2.55K Jun 7, 2023
Mario Crovetto Director $2.55K Jun 7, 2023
Yvonne Schlaeppi Director $2.55K Jun 7, 2023
Timothy C. Dec Chief Financial Officer $1.28K May 17, 2021
AEI Capital Ltd 10%+ Owner $0 Aug 5, 2024
Albert Weber Chief Finanical Officer Mar 2, 2023
Mohd Azham Azudin Coo Dec 4, 2024
Christian-Laurent Bonte Director Nov 6, 2024
Victor Chua Kok Hoe Director Nov 6, 2024
Ken Lim Zhao Qi Director Nov 6, 2024
Ethan Low Yu Jie Director Nov 6, 2024
Constance Wong Poh Yin Director Nov 6, 2024
Gillian Tan Rou Yee Corporate Secretary Dec 4, 2024

Recent Insider Transactions by Companies or Individuals for Opgen Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.